Page 2 of 2 FirstFirst 12
Results 11 to 12 of 12

Thread: InVivo Therapeutics Presents Data on Novel Hydrogel Technology in Spinal Cord Injury

  1. #11
    Quote Originally Posted by dr.zapp View Post
    Going to the moon is 1st grade math compared to regenerating neurons in a clinically relevant manner.
    dr.zapp,it's rather proofless and,to my mind,incorrect statement;what make you to believe so? I suppose that there is mainly an issue of priorities and ambitions though,not difficulty or easiness resolving of the launched task.By the way,what is your solution for this task:48/2(9+3)=?. Mine is "2",but I'm not sure.

  2. #12
    InVivo Therapeutics to Present at RedChip Virtual Equities Conference April 20, 2011

    CAMBRIDGE, MA, Apr 19, 2011 (MARKETWIRE via COMTEX) -- InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that it will present at the RedChip Small-Cap Equities Virtual Conference VII, to take place April 19-20, 2011.

    Frank Reynolds, Chairman & CEO of InVivo Therapeutics, is scheduled to present on Wednesday, April 20, 2011 at 9:30 a.m. EDT. Following the online presentation, investors will have the opportunity to speak one-on-one with Mr. Reynolds during a 15-minute question-and-answer session. The presentation and question-and-answer session will be webcast live at and will be archived for a minimum of 30 days.

Similar Threads

  1. Replies: 1
    Last Post: 03-12-2011, 01:20 AM
  2. Replies: 0
    Last Post: 07-10-2008, 04:02 PM
  3. Acorda Therapeutics CEO Inducted into Spinal Cord Injury Hall of Fame
    By Max in forum Funding, Legislation, & Advocacy
    Replies: 3
    Last Post: 11-13-2007, 01:55 PM
  4. Replies: 2
    Last Post: 10-26-2005, 06:25 PM
  5. Replies: 18
    Last Post: 06-08-2005, 12:00 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts